Variables | Unadjusted odds ratio (95% CI) n = 166 | P value | Adjusted odds ratioA (95% CI) n = 166a | P value | Adjusted odds ratioB (95% CI) n = 158a | P value |
---|---|---|---|---|---|---|
Age (y) | 0.96 (0.93–0.99) | 0.003 |  |  |  |  |
Male sex | 0.82 (0.35–1.95) | 0.655 |  |  |  |  |
Cardiac arrest witnessed | 1.07 (0.48–2.38) | 0.876 |  |  |  |  |
Bystander CPR attempt | 2.70 (1.20–6.06) | 0.016 |  |  |  |  |
Initial recorded cardiac arrest rhythm |  |  | 0.62 (0.42–0.93) | 0.02 | 0.63 (0.42–0.95) | 0.028 |
 VF or pulseless VT | 0.78 (0.28–2.19) | 0.641 |  |  |  |  |
 Pulseless electrical activity | 0.96 (0.28–3.36) | 0.954 |  |  |  |  |
 Asystole | 1.000 (ref.) | 0.850 |  |  |  |  |
Gasping during transportation by EMS | 8.37 (3.64–19.27) | <.001 | 9.52 (5.31–17.08) | < .001 | 9.94 (5.49–18.00) | < .001 |
Aetiology of cardiac arrest | 0.59 (0.25–1.38) | 0.225 |  |  |  |  |
Epinephrine dose before hospital admission, mg | 0.70 (0.54–0.92) | 0.009 |  |  |  |  |
Cardiac rhythm at admission | ||||||
 ROSC | 8.25 (1.58–43.13) | 0.012 |  |  |  |  |
 VF or pulseless VT | 1.77 (0.54–5.79) | 0.344 |  |  |  |  |
 Pulseless electrical activity | 0.72 (0.18–2.80) | 0.633 |  |  |  |  |
 Asystole | 1.000 (ref.) | 0.013 |  |  |  |  |
Low-flow duration, min | 0.98 (0.95–1.00) | 0.075 | 0.99 (0.97–1.01) | 0.34 | 0.99 (0.97–1.01) | 0.510 |
No-flow duration, min, n = 115b | 0.88 (0.80–0.98) | 0.018 |  |  |  |  |
pH at admission, n = 162c | 9.88 (0.77–127.38) | 0.079 |  |  |  |  |
Serum lactate value at admission, n = 158c | 1.01 (0.93–1.10) | 0.783 |  |  | 1.03 (0.97–1.09) | 0.399 |
Epinephrine administration after admission, mg | 0.76 (0.57–1.02) | 0.070 |  |  |  |  |
Intra-aortic balloon pumping | 1.36 (0.59–3.17) | 0.471 |  |  |  |  |
Percutaneous coronary intervention | 0.94 (0.44–1.98) | 0.865 |  |  |  |  |
Therapeutic temperature management | 1.62 (0.70–3.74) | 0.261 |  |  |  |  |